Preclinical Data Support Potential for APVO442 in Difficult-to-Treat Types of Prostate Cancer, Including Metastatic Castration-Resistant DiseaseSEATTLE, WA / ACCESSWIRE /...
Management will host an investor conference call today, Tuesday, at 8 a.m. Eastern.Company pivots towards RNA therapeutics and its OligoPhore™...
• Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites...
VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“the Company”), a biopharmaceutical company committed...
Former UnitedHealth Group Executive to Help Lead Growth in Health Plan and Provider MarketsMINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) --...
XP Health’s AI-powered Vision Platform to Deliver Enhanced Group Benefits with Noyo IntegrationSAN CARLOS, Calif. and SAN FRANCISCO, April 12, 2022...
Upcoming Change Reflects the Company’s Focus on Oral Delivery of BiotherapeuticsSAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc....
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia,...
LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based...
MALVERN, Pa., April 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and...
VANCOUVER, Washington, April 12, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company...
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer...
Halo’s Ground-Breaking Brand of Super Premium, Natural Pet Food will be Available at 600+ Pet Supplies Plus Locations Beginning in...
The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancerMINNEAPOLIS, April 12, 2022 (GLOBE...
SOUTH SAN FRANCISCO, Calif., April 12, 2022 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...
LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines,...
FREDERICK, Md., April 12, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes...
PASADENA, CA, April 12, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on...
FOR IMMEDIATE RELEASE All Four Proposals Approved NEW YORK, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:...
Calgary, Alberta--(Newsfile Corp. - April 12, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is...